This review highlights the importance of managing traditional cardiovascular risk factors in patients with chronic kidney disease to mitigate their increased risk of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Reinforces CV risk factor management in CKD; leaves optimal targets and therapies open for dedicated trials.
Uhlig et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: